July 10, 2020
Engineers at Johns Hopkins have solved the problem of distorted imaging scans that plague surgeons who need to use them to assess the placement of metal implants.
July 7, 2020
In experiments in rats and mice, two Johns Hopkins scientists — an engineer and an ophthalmologist — report the successful use of nanoparticles to deliver gene therapy for blinding eye disease.
June 10, 2020
Johns Hopkins scientists studying the virus that causes COVID-19 say the pathogen has few variations, a promising observation that boosts the chances of developing an effective vaccine.
May 20, 2020
A team of researchers and students at Johns Hopkins are working to replenish the diminishing reserve of kidney dialysis fluid to help those with acute kidney injury, including COVID-19 patients who develop the disorder.
May 19, 2020
Johns Hopkins researchers report they have identified a drug treatment that could—if given early enough—potentially reduce the risk of death from the most serious complication of COVID-19, also known as SARS-CoV-2 infection.
May 18, 2020
Johns Hopkins researchers recently received a $195,000 Rapid Response Research grant from the National Science Foundation to, using machine learning, identify which COVID-19 patients are at risk of adverse cardiac events such as heart failure, sustained abnormal heartbeats, heart attacks, cardiogenic shock and death.
April 17, 2020
When scientists scour the genome for disease-causing culprits, they wouldn’t ordinarily look in so-called noncoding regions, areas of repetitive DNA that do not code for proteins. Yet, that’s exactly where Johns Hopkins scientists found genomic variations in a new study of people with heart failure.
Johns Hopkins biomedical engineer Jordan Green and his colleagues have developed a nanoparticle that has the shape and “skin” of red blood cells. The red blood cell mimics can be injected into the bloodstream and circulate within vessels for long periods to absorb toxic substances.
March 6, 2020
Johns Hopkins researchers have created a computer program for scientists at no charge that lets users readily quantify the structural and functional changes in the blood flow networks feeding tumors.